(Q72919943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Hepatitis B antigen in the liver in hepatocellular carcinoma in shikoku, Japan (English)

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

14 September 2023

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

14 September 2023

author name string

G. Akagi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6275977

14 September 2023

K. Furuya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6275977

14 September 2023

H. Otsuka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6275977

14 September 2023

language of work or name

English

0 references

publication date

1 February 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

15 February 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6275977

full work available at URL

14 September 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

14 September 2023

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

14 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

678-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum

30 October 2019

cites work

1

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

A case/control study of the association between primary liver cancer and hepatitis b infection in senegal

14 September 2023

5

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis B and primary hepatocellular carcinoma in a European population

14 September 2023

7

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Orcein staining of hepatitis B antigen in paraffin sections of liver biopsies

14 September 2023

10

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods

14 September 2023

14

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Detection of Hepatitis B Surface Antigen by Means of Orcein Staining of Liver

14 September 2023

15

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

14 September 2023

16

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Cirrhosis and hepatoma occurring at Boston City Hospital (1917-1968)

14 September 2023

18

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

A clinicopathological review of 100 cases of primary malignant tumours of the liver

14 September 2023

19

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

The Changing Incidence of Association of Hepatitis B with Hepatocellular Carcinoma in California

14 September 2023

20

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatocellular carcinoma and hepatic cirrhosis in the west of Scotland: a 25-year necropsy review

14 September 2023

21

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma

14 September 2023

25

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans

14 September 2023

26

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis-b antigen and cirrhosis in bantu patients with primary liver cancer

14 September 2023

27

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan

14 September 2023

28

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer

14 September 2023

29

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver

14 September 2023

30

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis B Virus Infection and Primary Hepatocellular Carcinoma 2 3

14 September 2023

31

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma

14 September 2023

32

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue

14 September 2023

34

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Geographic correlation between mortality from primary hepatic carcinoma and prevalence of hepatitis B surface antigen in Greece

14 September 2023

35

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Primary liver cell carcinoma in the presence or absence of hepatitis b antigen

14 September 2023

36

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Cytoplasmic Hepatitis B Surface Antigen and the Ground-glass Appearance in Hepatocellular Carcinoma

14 September 2023

37

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa

14 September 2023

38

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Primary liver cancers in Japan

14 September 2023

39

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Association between aflatoxin content of food and hepatoma frequency in Uganda

14 September 2023

40

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Hepatitis Bs antigen and liver cancer: A population based study in Kenya

14 September 2023

41

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Dietary aflatoxins and liver cancer – a population based study in Kenya

14 September 2023

42

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma

14 September 2023

43

1 reference

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(19820215)49:4%3C678::AID-CNCR2820490416%3E3.0.CO;2-F

14 September 2023

Identifiers

10.1002/1097-0142(19820215)49:4<678::AID-CNCR2820490416>3.0.CO;2-F

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275977%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference